Warren Buffett Criticizes Trump’s Tariffs As A ‘Tax On Goods’
Legendary investor Warren Buffett has taken the unusual step of speaking publicly about politics and criticizing the U.S. president’s policies. In this case, Buffett criticized U.S. President Donald Trump’s tariff measures, saying the duties placed on foreign imports entering America could trigger inflation and hurt consumers.“Tariffs are actually, we’ve had a lot of experience with them. They’re an act of war, to some degree,” said Buffett in a television interview with CBS News. “Over time, they are a tax on goods. I mean, the Tooth Fairy doesn’t pay ’em,” said Buffett, who is age 94, adding, “And then what? You always have to ask that question in economics. You always say, ‘And then what?’”Buffett’s comments come as the Trump administration prepares to implement sweeping 25% tariffs on most imports from Mexico and Canada on March 4.Trump is also placing an additional 10% tariff on Chinese imports, bringing the total duty on those goods to 20%. Buffett has spoken at length in the past about how damaging trade conflicts can be and warning that tariffs have negative consequences for the global economy. The latest comments on tariffs also come as Buffett remains on the defensive with his investment portfolio, selling stocks and raising a record amount of cash that totaled more than $300 billion U.S. at the end of last year. Some analysts have speculated that Buffett is bearish on the current stock market and U.S. economy. However, Buffett himself has refrained from commenting on his stock buys and sells. Buffett’s holding company, Berkshire Hathaway (BRK.B) has seen its more affordable Class B stock rise 14% so far this year to trade at $513.83 U.S. per share.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


